We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Very Low Body Fat Linked to Higher Risk of Death in Dialysis Patients

By HospiMedica International staff writers
Posted on 13 Nov 2009
Dialysis patients with low body fat are at increased risk of death, even compared to patients at the highest level of body fat percentage, claims a new study.

Researchers at the Los Angeles Biomedical Research Institute (LABioMed; CA, USA) used near-infrared interactance technology to measured body fat percentage in 671 hemodialysis patients from eight California (USA) dialysis centers. More...
They then compared five-year mortality rates for patients at different levels of body fat percentage. The researchers found that mortality rate was highest for dialysis patients with less than 10% body fat, which was 2.5-3 times higher than for those with body fat of 20 to 30%. The increased risk of death for patients with very low body fat remained after adjustment for age, sex, race, other illnesses, and key laboratory results. Further analyses using continuous values of body fat (rather than categories) confirmed a direct, linear relationship between body fat and mortality risk. The study was presented at the annual meeting American Society of Nephrology, held during November 2009 in San Diego (CA, USA).

"The results add to the increasing number of reports about the 'obesity paradox' or 'reverse epidemiology' in patients with chronic kidney disease and other chronic diseases,” said Kamyar Kalantar-Zadeh, Ph.D., of LABioMed. "Counter-intuitively, higher body mass index is associated with greater survival in hemodialysis patients.”

Reverse epidemiology, a term coined by Dr. Kalantar-Zadeh in 2003, refers to a medical hypothesis which holds that obesity and high cholesterol may be protective and associated with greater survival in certain groups of people, such as very elderly individuals or those with certain chronic diseases. It further postulates that normal to low body mass index (BMI), or normal values of cholesterol may be detrimental and associated with higher mortality in asymptomatic people.

Related Links:

Los Angeles Biomedical Research Institute




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.